Drug intelligence / Profile preview

Tears Again

Development stage
Unknown
Lead developer
Optima Pharmazeutische
Administration
Ophthalmic
01

Overview

**Tears Again** is a preservative-free liposomal eye spray marketed as a medical device for symptomatic treatment of dry eye disease, particularly evaporative dry eye associated with tear-film lipid-layer deficiency. The spray is applied to closed eyelids; phospholipid liposomes distribute onto the ocular surface during blinking and stabilize the tear film's protective lipid layer, reducing tear evaporation and improving ocular-surface moisturization. Clinical studies have reported improvement in dry-eye symptoms and non-invasive tear break-up time, with favorable handling and tolerability assessments. Tears Again is manufactured and marketed by Optima Pharma and has also been clinically sponsored in Israel by Trima Israel Pharmaceutical Products.

Brand names
Optrex ActiMistTears Again
Other names
Tears Again Eye SprayTears Again liposomal sprayTears Again Original

Beyond the preview

Go deeper on Tears Again.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tears Again.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call